| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.17 | 9e-06 |